Pulsetto
Vilnius, LithuaniaFounded 2021
- Neuromodulation
- Seed
Pulsetto develops consumer wellness devices that use vagus nerve stimulation to support relaxation and help users manage stress and anxiety. Its product range includes Pulsetto Lite, Pulsetto FIT, and Pulsetto FIT X, alongside a premium app subscription.
- RaisedTotal raised
- $3.5M
- Feb 2025Latest priced round, Feb 2025
- Seed
- Investors
- 2
- Founded
- 2021
- Employees
- 11–50
reccy insights
Pulsetto’s milestones point to expanding consumer reach and a broader emphasis on nervous-system training. On Aug 20, 2025, the company was named Expert Consumers’ top vagus nerve stimulation device for general wellness. A Nov 24, 2025 announcement said Pulsetto had surpassed 100,000 users worldwide, giving a concrete adoption milestone, though it does not disclose retention or revenue. On Jan 8, 2026, Pulsetto announced an integration partnership with Spike API to connect wearable data with its stress-management offering. The company’s 2026 communications also extended its message beyond relaxation: a June 1 announcement discussed nervous-system training for runners, and a July 27 item described NBA players using stress fitness for recovery. These developments suggest the company is broadening its use cases from consumer stress and sleep support toward athletic recovery and wearable-enabled programs. The available announcements do not provide independent study results, commercial terms for the integration, or quantified outcomes from the sports-related initiatives, so their business impact remains unclear.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
What makes Pulsetto distinct
- 01Offers vagus nerve stimulation devices focused on relaxation and stress management.
- 02Promotes guided sessions designed to help users relax in under 10 minutes.
- 03Offers multiple device models, including Pulsetto Lite, Pulsetto FIT, and Pulsetto FIT X.
- 04Pairs its devices with a premium app subscription and guided wellness content.
Technology & products7
- Pulsetto FIT
A wearable, non-invasive vagus nerve stimulation device used with a smartphone app to support relaxation, stress management, sleep, and nervous-system regulation.
- Pulsetto Lite
A compact, non-invasive vagus nerve stimulation device that delivers guided sessions through the Pulsetto smartphone app for stress relief, relaxation, and sleep support.
- Pulsetto App Premium
A subscription-based mobile app upgrade with additional stimulation programs, breathing exercises, meditations, wellness insights, and wearable connectivity.
+ 4 more: Pulsetto Gelbox, Travel Case for Pulsetto FIT, Travel Case for Pulsetto Lite, Pulsetto FIT X
Recent updates2
- Jan 8, 2026Partnership
Pulsetto announced a partnership with Spike API to support wearable integration for stress management.
einpresswire.com - Aug 20, 2025Award
Top Vagus Nerve Stimulation Device for General Wellness
In the Cortex
- Nuropod vs. Pulsetto for Sleep: I Used Both for Weeks. Only One Doesn't Disrupt My Sleep While Promising to Support ItGadget Review · Nov 4, 2026
- Meet the new Pulsetto FIT XWFLA · Oct 22, 2026
- Meet the New Pulsetto FIT X | BloomWFLA · Oct 19, 2026
Funding
- SeedFeb 2025$2.1MLed by ScaleWolf
- SeedFeb 2025$419K
- EU Funding GrantNov 2023European Regional Development Fund
Similar companies
About Pulsetto
- Products
- Pulsetto FIT, Pulsetto Lite, Pulsetto App Premium, Pulsetto Gelbox, Travel Case for Pulsetto FIT, Travel Case for Pulsetto Lite, Pulsetto FIT X
- Leadership
- Povilas Sabaliauskas, Co-Founder & CEOVitalijus Majorovas, Co-Founder
- Focus areas
- NeuroTechnology, medical devices, digital health, wellness, wearables, vagus nerve stimulation, stress management
- Headquarters
- Vilnius, Lithuania
- Founded
- 2021
- Employees
- 11–50